Zhejiang Starry Pharm Co Ltd (603520) — Cash Flow Quality Index
Zhejiang Starry Pharm Co Ltd (603520) has a Cash Flow Quality Index of 3.54x as of June 2025. Operating cash flow of CN¥52.35 Million exceeds net income of CN¥14.79 Million, indicating high earnings quality where cash backs reported profits. Explore 603520 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Starry Pharm Co Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Zhejiang Starry Pharm Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Starry Pharm Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Starry Pharm Co Ltd (2011–2025)
Year-by-year earnings quality comparison for Zhejiang Starry Pharm Co Ltd. For live market cap and the full company financial profile, see 603520 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | CN¥3.67 Million | CN¥10.23 Million | ▼ -65.6% |
| 2023 | 1.04x | CN¥46.13 Million | CN¥44.23 Million | ▼ -32.4% |
| 2021 | 1.54x | CN¥508.84 Million | CN¥329.77 Million | ▲ +124.3% |
| 2020 | 0.69x | CN¥174.48 Million | CN¥253.60 Million | ▼ -49.0% |
| 2019 | 1.35x | CN¥246.77 Million | CN¥182.92 Million | ▼ -32.8% |
| 2018 | 2.01x | CN¥191.84 Million | CN¥95.54 Million | ▲ +803.1% |
| 2017 | 0.22x | CN¥18.10 Million | CN¥81.42 Million | ▲ +119.8% |
| 2016 | 0.10x | CN¥7.68 Million | CN¥75.91 Million | ▼ -92.2% |
| 2015 | 1.29x | CN¥94.88 Million | CN¥73.47 Million | ▼ -39.9% |
| 2014 | 2.15x | CN¥144.00 Million | CN¥67.03 Million | ▲ +79.9% |
| 2013 | 1.19x | CN¥74.99 Million | CN¥62.80 Million | ▼ -59.6% |
| 2012 | 2.95x | CN¥103.34 Million | CN¥35.00 Million | ▲ +584.0% |
| 2011 | -0.61x | CN¥-41.07 Million | CN¥67.33 Million | — |